Citadel Advisors’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.46M | Buy |
182,346
+110,471
| +154% | +$1.49M | ﹤0.01% | 2505 |
|
2025
Q1 | $622K | Buy |
71,875
+30,826
| +75% | +$267K | ﹤0.01% | 3764 |
|
2024
Q4 | $199K | Sell |
41,049
-34,729
| -46% | -$169K | ﹤0.01% | 4898 |
|
2024
Q3 | $585K | Sell |
75,778
-26,675
| -26% | -$206K | ﹤0.01% | 3640 |
|
2024
Q2 | $1.02M | Buy |
102,453
+50,252
| +96% | +$503K | ﹤0.01% | 3010 |
|
2024
Q1 | $634K | Sell |
52,201
-60,044
| -53% | -$730K | ﹤0.01% | 3643 |
|
2023
Q4 | $1.61M | Buy |
112,245
+59,206
| +112% | +$847K | ﹤0.01% | 2592 |
|
2023
Q3 | $413K | Sell |
53,039
-37,442
| -41% | -$291K | ﹤0.01% | 3961 |
|
2023
Q2 | $1.29M | Sell |
90,481
-98,104
| -52% | -$1.4M | ﹤0.01% | 2762 |
|
2023
Q1 | $2.76M | Buy |
188,585
+31,409
| +20% | +$460K | ﹤0.01% | 2260 |
|
2022
Q4 | $2.64M | Buy |
157,176
+58,498
| +59% | +$983K | ﹤0.01% | 2333 |
|
2022
Q3 | $1.46M | Buy |
+98,678
| New | +$1.46M | ﹤0.01% | 3048 |
|
2022
Q2 | – | Sell |
-52,488
| Closed | -$1.98M | – | 6664 |
|
2022
Q1 | $1.98M | Buy |
+52,488
| New | +$1.98M | ﹤0.01% | 3020 |
|
2021
Q4 | – | Sell |
-12,192
| Closed | -$1.04M | – | 6951 |
|
2021
Q3 | $1.04M | Sell |
12,192
-5,935
| -33% | -$508K | ﹤0.01% | 3733 |
|
2021
Q2 | $1.12M | Buy |
18,127
+11,103
| +158% | +$687K | ﹤0.01% | 3879 |
|
2021
Q1 | $342K | Sell |
7,024
-20,744
| -75% | -$1.01M | ﹤0.01% | 4907 |
|
2020
Q4 | $865K | Buy |
+27,768
| New | +$865K | ﹤0.01% | 3388 |
|